Cargando…
The story of artesunate–mefloquine (ASMQ), innovative partnerships in drug development: case study
BACKGROUND: The Drugs for Neglected Diseases initiative (DNDi) is a not-for profit organization committed to providing affordable medicines and access to treatments in resource-poor settings. Traditionally drug development has happened “in house” within pharmaceutical companies, with research and de...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2013
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3640935/ https://www.ncbi.nlm.nih.gov/pubmed/23433060 http://dx.doi.org/10.1186/1475-2875-12-68 |